跳至主要内容
临床试验/NCT03182062
NCT03182062Unknown不适用

Postoperative Complication and Hospital Stay Reduction With a Individualized Perioperative Lung Protective Ventilation During One-lung Ventilation: A Prospective, Multicenter, Randomized Trial

Fundación para la Investigación del Hospital Clínico de Valencia8 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2018年9月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
1,400
试验地点
8
主要终点
Reduction of postoperative pulmonary complications

研究概览

简要总结

The purpose of this study is to determine whether individualized ventilatory management during one-lung ventilation in patients scheduled for thoracic surgery, combining the use of low tidal volumes, alveolar recruitment maneuvers, individually titrated positive end-expiratory pressure and individually indicated ventilatory support will decrease postoperative pulmonary complications, ICU and hospital length of stay compared to a standardized Lung Protective Ventilation (LPV).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Planned thoracic surgery > 2 hours.
  • Signed informed consent for participation in the study.

排除标准

  • Age less than 18 years.
  • Pregnant or breast-feeding.
  • Patients with BMI >
  • Syndrome of moderate or severe respiratory distress: PaO2/FiO2 < 200 mmHg.
  • Heart failure: NYHA IV.
  • Hemodynamic failure: CI <2.5 L/min/m2 and / or requirements before surgery ionotropic support.
  • Diagnosis or suspicion of intracranial hypertension (intracranial pressure> 15 mmHg).
  • Mechanical ventilation in the last 15 days.
  • Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT).
  • Patient with preoperatively CPAP.
  • Participation in another experimental protocol at the time of intervention selection.

研究组 & 干预措施

OLA-iHFNC

Active Comparator

Intraoperatively ventilated patients with a tidal volume (VT) of 5-6ml / kg of ideal body weight and respiratory rate to maintain normal carbon dioxide. After intubation, in all patients will be performed an alveolar recruitment maneuver (MRA) and a PEEP titration trial (see Calculation of optimal PEEP). Every 40 minutes will be assessed the need to adjust the level of PEEP by evaluating the dynamic compliance of the respiratory system (Crs). Faced with a decline in Crs> 10% a new MRA and optimal PEEP setting will be assessed.

Postoperatively, high flow oxygen therapy will be individually indicated by evaluating peripheral oxygen saturation.

干预措施: Alveolar recruitment maneuver (Procedure)

OLA-iHFNC

Active Comparator

Intraoperatively ventilated patients with a tidal volume (VT) of 5-6ml / kg of ideal body weight and respiratory rate to maintain normal carbon dioxide. After intubation, in all patients will be performed an alveolar recruitment maneuver (MRA) and a PEEP titration trial (see Calculation of optimal PEEP). Every 40 minutes will be assessed the need to adjust the level of PEEP by evaluating the dynamic compliance of the respiratory system (Crs). Faced with a decline in Crs> 10% a new MRA and optimal PEEP setting will be assessed.

Postoperatively, high flow oxygen therapy will be individually indicated by evaluating peripheral oxygen saturation.

干预措施: PEEP Titration Trial (Procedure)

STD-O2

Active Comparator

Intraoperatively ventilated patients with a tidal volume of 5-6 ml / kg of ideal body weightand respiratory rate to maintain normal carbon dioxide, PEEP 5 cmH2O. In this group no recruitment maneuvers or optimal PEEP setting will be performed.

Postoperatively, standard oxygen therapy.

干预措施: Lung protective ventilation (Procedure)

结局指标

主要结局

Reduction of postoperative pulmonary complications

时间窗: Up to 7 postoperative days

composite of pulmonary infection, severe respiratory failure, acute respiratory distress syndrome, pneumothorax, bronchopleural fistula, atelectasis requiring bronchoscopy, empyema.

次要结局

  • Reduction of composite of postoperative complications(Up to 7 and 30 postoperative days)
  • Reduction of composite of postoperative pulmonary complications(Up to 30 postoperative days)
  • Intensive care unit and hospital length of stay reduction(1 year)

研究者

发起方
Fundación para la Investigación del Hospital Clínico de Valencia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlos Ferrando

Principal Investigador

Fundación para la Investigación del Hospital Clínico de Valencia

研究点 (8)

Loading locations...

相似试验